Skip to main content

Advertisement

Log in

The neutrophil-to-lymphocyte ratio as a marker of peripheral inflammation in progressive supranuclear palsy: a retrospective study

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Background and purpose

To evaluate the neutrophil-to-lymphocyte ratio (NLR) levels in the peripheral blood of patients with progressive supranuclear palsy (PSP), and to compare them with levels in patients with idiopathic Parkinson’s disease (PD) and healthy controls.

Methods

Twenty-one patients with probable PSP, 42 with PD, and 40 age-matched healthy volunteers were enrolled in the study. Demographic data and duration of disease, comorbid systemic disease, and smoking status were recorded. NLR was calculated by dividing neutrophil count by the lymphocyte count.

Results

The mean age of patients with PSP was 68.28 ± 8.7 years and the mean duration of disease was 5.09 ± 2.52 years. The mean age in PD group was 66.59 ± 9.54 years and 65.05 ± 6.52 years in the healthy volunteer group. There were no significant differences in ages between the PSP group and the other two groups (p = 0.498; p = 0.107, respectively). The PSP group consisted of four female and 17 male patients. The PD group comprised 19 female and 23 male patients. There were 18 female and 2 male in the healthy volunteer group. The mean NLR value in the PSP group was significantly higher than in the PD group and healthy controls (p = 0.023; p = 0.001, respectively). The mean NLR value in the PD group was not significantly different from the healthy controls (p = 0.593).

Conclusion

NLR values were found higher in the PSP group. The result of this study revealed the existence of peripheral inflammation in patients with PSP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and serebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10(4):333–359

    Article  CAS  Google Scholar 

  2. Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Höglinger GU (2017) Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol 16(7):552–563

    Article  Google Scholar 

  3. Kovacs G (2015) Neuropathology of tauopaties: principles and practice. Neuropathol Appl Neurobiol 41(1):3–23

    Article  CAS  Google Scholar 

  4. Ishizawa K, Dickson DW (2001) Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. J Neuropathol Exp Neurol 60(6):647–657

    Article  CAS  Google Scholar 

  5. Chitnis T, Weiner HL (2017) CNS inflammation and neurodegeneration. Jci1 27(10):3577–3587

    Article  Google Scholar 

  6. Khandelwal PJ, Herman AM, Moussa CE-H (2011) Inflammation in the early stages of neurodegenerative pathology. J Neuroimmunol 238(1–2):1–11

    Article  CAS  Google Scholar 

  7. Zahorec R (2001) Ratio of neutrophil to lymphocyte count: rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102(1):5–14

    CAS  PubMed  Google Scholar 

  8. Kuyumcu ME, Yeşil Y, Ozturk ZA, Kızılarslanoglu C, Atgul S, Halil M et al (2012) The evaluation of neutrophil-lymphocyte ratio in Alzheimer’s disease. Dement Geriatr Cogn Disord 34(2):69–74

    Article  Google Scholar 

  9. Rembach A, Watt AD, Wilson WL, Rainey-Smith S, Ellis KA, Rowe CC, Villemagne VL, Macaulay SL, Bush AI, Martins RN, Ames D, Masters CL, Doecke JD, AIBL Research Group (2014) An increased neutrophil-lymphocyte ratio in Alzheimer’s disease is function of age and is weakly correlated with neocortical amyloid accumulation. J Neuroimmunol 273(1–2):65–71

    Article  CAS  Google Scholar 

  10. Akıl E, Bulut A, Kaplan I, Ozdemir HH, Arslan D, Aluçlu MU (2015) The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson’s disease. NeurolSci 36(3):423–428

    Google Scholar 

  11. Kücük E, Kocayiğit İ, Günel C, Düzenli H (2016) Neutrophil-to-lymphocyte ratio in occlusive vascular disease: the literature review of the past 10 years. World J Emerg Med 7(3):165–172

    Article  Google Scholar 

  12. Ozbay I, Kahraman C, Balıkcı HH, Kucur C, Karaman NK, Ozkaya DP (2014) Neutrophil-to-lymphocyte ratio inpatients with peripheral vertigo: a prospective controlled clinical study. Am J Otolaryngol 35(6):699–702

    Article  Google Scholar 

  13. Corriere T, Marca D, Cataudella E, Pulvirenti A, Stancanelli SA, Malatino L (2018) Neutrophil-to-lymphocyte ratio is a strong predictor of atherosclerotic carotid plaque in older adults. Nutr Metab Cardiovasc Dis 28(1):23–27

    Article  CAS  Google Scholar 

  14. Woong Nam K, Min Kwon H, YeongJeong H, Ho Park J, Kim SH, Min Jeong S (2018) High neutrophil-to-lymphocyte ratio predict intracranial atherosclerosis in healthy population. Atherosclerosis 269:117–121

    Article  Google Scholar 

  15. Zeng Z, Wang C, Wang B, Wang N, Yang Y, Guo S, Du Y (2019) Prediction of neutrophil-to-lymphocyte ratio in the diagnosis and progression autoimmune encephalitis. Neurosci Lett 694:129–135

    Article  CAS  Google Scholar 

  16. Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang A et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorders society criteria. Mov Disord 32(6):853–864

    Article  Google Scholar 

  17. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) The accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinic pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184

    Article  CAS  Google Scholar 

  18. Fernandez-Botran R, Ahmed Z, Crespo FA, Gatenbee C, Gonzalez J, Dickson S et al (2011) Cytokine expression and microbial activation in progressive supranuclear palsy. Parkinsonism Relat Disord 17(9):683–688

    Article  Google Scholar 

  19. Hasson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U et al (2017) Blood based Nfl: a biomarker for differential diagnosis of parkinsonian disorder. Neurology 88(10):930–937

    Article  Google Scholar 

  20. Donker Kaat L, Meeter LH, Chiu WZ, Melhem S, Boon AJW, Blennow K et al (2018) Serum neurofilament light chain in progressive supranuclear palsy. Parkinson Relat Disorders 56:98–101

    Article  Google Scholar 

  21. Magdalinou NK, Paterson RW, Schott JM, Fox NC, Mummery C, Blennow K et al (2015) A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian symptoms. J Neurol Neurosurg Psychiatry 86(11):1240–1247

    Article  CAS  Google Scholar 

  22. Olsson B, Constantinescu R, Holberg B, Andreassen N, Blennow K, Zetterberg H (2013) The glial marker YKL-40 is decreased in synucleinopathies. Mov Disord 28(13):1882–1885

    Article  CAS  Google Scholar 

  23. Ferrari CC, Tarelli R (2011) Parkinson’s disease and systemic inflammation. Parkinson’s Dis 436813. https://doi.org/10.4061/2011/436813

  24. Azab B, Camacho-Rivera M, Taioli E (2014) Average values and racial differences of neutrophil-lymphocyte ratio among a nationally representative sample of United States subjects. PLoS One 9(11):e112361

    Article  Google Scholar 

  25. Wang X, Zhang G, Jiang X, Zhu H, Lu Z, Xu L (2014) Neutrophil to lymphocyte ratio in relation to risk of all cause of mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis observational studies. Atherosclerosis 234(1):206–213

    Article  CAS  Google Scholar 

  26. Eryıgıt U, AltunayogluCakmak V, Sahin A, Tatlı O, Paslı S, Gazioglu G et al (2017) The diagnostic value of the neutrophil-lymphocyte ratio in distinguishing between subarachnoid hemorage and migraine. Am J Emerg Med 35(9):1276–1280

    Article  Google Scholar 

  27. Ucar Ataç C, Cokal BG, Artık UHA, Inan LE, Yoldas TK (2017) Comparison of neutrophil-lymphocyte ratio (NLR) in Parkinson’s disease subtypes. Neurol Sci 38(2):287–293

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ipek Inci.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The local ethics committee approved the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

None of the parts of this original article entitled as “The neutrophil-to-lymphocyte ratio as a marker of peripheral inflammation in progressive supranuclear palsy: a retrospective study” has had prior or duplicate publication or submission elsewhere.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Inci, I., Kusbeci, O.Y. & Eskut, N. The neutrophil-to-lymphocyte ratio as a marker of peripheral inflammation in progressive supranuclear palsy: a retrospective study. Neurol Sci 41, 1233–1237 (2020). https://doi.org/10.1007/s10072-019-04208-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-019-04208-4

Keywords

Navigation